Increased FDG Uptake in Skin Rashes Caused by EGFR Inhibitors.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 36469080.
- Also identified by DOI 10.1097/RLU.0000000000004478.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Most patients treated with epidermal growth factor receptor inhibitors develop cutaneous advance effects. The extent and severity of treatment-related skin rashes are associated with good treatment response and prognosis. Herein, we presented increased uptake of the 18F-FDG in skin rashes after treatment with epidermal growth factor receptor inhibitors in 2 patients diagnosed with metastatic colorectal cancer.
Medical subject headings
- Exanthema
- Fluorodeoxyglucose F18
- Protein Kinase Inhibitors